Journal
Lancet Infectious DiseasesPubMed ID
23257228Language
enISSN
1474-4457ae974a485f413a2113503eed53cd6c53
10.1016/S1473-3099(12)70299-2
Scopus Count
Collections
Related articles
- Linezolid for multidrug-resistant tuberculosis.
- Authors: Chang KC, Leung CC, Daley CL
- Issue date: 2012 Jul
- Linezolid for multidrug-resistant tuberculosis - authors' reply.
- Authors: Chang KC, Leung CC, Daley CL
- Issue date: 2013 Jan
- Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
- Authors: Yew WW, Chang KC, Chau CH
- Issue date: 2009 Nov
- [Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
- Authors: Valencia ME, Moreno V, Laguna F, González-Lahoz JM
- Issue date: 2001 Jan
- Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
- Authors: Koh WJ, Shim TS
- Issue date: 2009 Nov